Anesthesia remains a dynamic industry as leaders explore new methods of opioid-free pain management and expand into new care settings. Christina Menor, MD, president-elect of the California Society of ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The following is a summary of “Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology,” published in the January 2025 issue of Pain by ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Citation: Walker J, Dimcea G (2025) Assessment and management of knee pain: taking a holistic approach. Nursing Times [online], 121; 2. Authors: Jennie Walker is principal lecturer and Gruia Dimcea is ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey ...